Yüklüyor......
Use of CA15-3 for screening breast cancer: An antibody-lectin sandwich assay for detecting glycosylation of CA15-3 in sera
Elevated serum CA15-3 assessed by enzyme-linked immunosorbent assay (ELISA) has been considered a diagnostic marker of breast cancer. However, accumulating data indicate that the current ELISA system for detecting CA15-3, which targets the peptide backbone of CA15-3, is not sufficiently sensitive to...
Kaydedildi:
| Yayımlandı: | Oncol Rep |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
D.A. Spandidos
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6059737/ https://ncbi.nlm.nih.gov/pubmed/29749490 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2018.6433 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|